Evaluation of the Role of Plasma Procalcitonin in Prediction of Intra-amniotic Infection in Preterm Premature Rupture of Membrane

NCT02104791 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 100

Last updated 2014-04-04

No results posted yet for this study

Summary

It is hypothesized that the procalcitonin has a role to play in prediction of intra-amniotic subclinical infection.

Conditions

  • Intra-amniotic Subclinical Infection.

Interventions

DRUG

procalcitonin

In patient with preterm premature rupture of membrane (PPROM) is the procalcitonin can be used to predict intra-amniotic subclinical infection?

Sponsors & Collaborators

  • Ain Shams Maternity Hospital

    lead OTHER

Eligibility

Min Age
20 Years
Max Age
40 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2014-05-31
Primary Completion
2015-05-31

Countries

  • Egypt

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02104791 on ClinicalTrials.gov